Viral Vector Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 396 Deals Signed Since 2016 by Company A-Z, Financial terms, Deal Type and Therapy Focus
January 03, 2025 11:07 ET
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
Precision Medicine in Oncology Collaboration and Licensing Deals Analysis Report 2024 with Directory of 821 Deals Signed Since 2016 by Company A-Z, Deal Type and Therapeutic Target
January 03, 2025 10:59 ET
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report...
Gene Therapy Agreements Analysis Report and Directory 2024: Comprehensive Listing of 740 Deals Announced Since 2016
July 17, 2024 05:31 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Gene Therapy Collaboration and...
Global Paternity & Relationship Testing Services Market Research 2024: Increased Competition Lowers Price, Cultural Shifts Changing Meaning of Family, Ancestry Influencing Changing Attitudes
July 15, 2024 04:47 ET
|
Research and Markets
Dublin, July 15, 2024 (GLOBE NEWSWIRE) -- The "Paternity & Relationship Testing Services: Global Market Forecast by Application and by Product with Executive and Consultant Guides" report has...
GeneType to Enter Canadian and New Zealand Markets
July 09, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType to Enter Canadian and New Zealand Markets
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
June 25, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
June 21, 2024 08:00 ET
|
Genetic Technologies Ltd
Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
June 05, 2024 08:00 ET
|
Genetic Technologies Ltd
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
GeneType and Humanise Health host “Know Your Risk” Event
May 23, 2024 08:00 ET
|
Genetic Technologies Ltd
"Know Your Risk" Event a remarkable success in Pasadena.
Viral Vector Collaboration, R&D, and Licensing Deals Trends Report 2024 with Directory of 396 Agreements Signed Since 2016
May 07, 2024 09:04 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Viral Vector Collaboration and...